Najib Babul
Overview
Explore the profile of Najib Babul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ranade S, Bajaj A, Londhe V, Babul N, Kao D
Eur J Pharm Sci
. 2017 Jan;
100:132-141.
PMID: 28069427
Topical film-forming metered dose spray formulations were designed for management of pain. Ropivacaine, a local anesthetic is explored for its topical efficacy in alleviating pain. Metered dose spray containers, organic...
2.
Christensen K, Cohen A, Mermelstein F, Hamilton D, McNicol E, Babul N, et al.
Anesth Analg
. 2008 Nov;
107(6):2018-24.
PMID: 19020153
Background: Opioids are standard treatment for postoperative pain. In this study, we compared the safety and efficacy of intranasal (i.n.) morphine to i.v. and oral morphine and placebo. Methods: Two-hundred-twenty-five...
3.
Sloan P, Babul N
Expert Opin Drug Deliv
. 2006 Jul;
3(4):489-97.
PMID: 16822224
Recent clinical trials have documented the use of extended-release (ER) opioids in the management of chronic non-malignant pain. This manuscript reviews the clinical pharmacology of investigational and current marketed ER...
4.
Babul N, Sloan P, Lipman A
Anesthesiology
. 2006 Jan;
104(2):375.
PMID: 16436859
No abstract available.
5.
Babul N, Sloan P, Lipman A
Anesth Analg
. 2006 Jan;
102(2):645-6.
PMID: 16428581
No abstract available.
6.
Matsumoto A, Babul N, Ahdieh H
Pain Med
. 2005 Nov;
6(5):357-66.
PMID: 16266356
Objective: To compare oxymorphone extended release (ER) and placebo on indices of pain, function, and safety in patients with chronic osteoarthritis (OA) pain. Design: In this multicenter, double-blind, placebo- and...
7.
Babul N, Noveck R, Chipman H, Roth S, Gana T, Albert K
J Pain Symptom Manage
. 2004 Jun;
28(1):59-71.
PMID: 15223085
The efficacy and safety of a once-daily extended-release formulation of tramadol hydrochloride (tramadol ER) was evaluated in patients with moderate to severe chronic pain of osteoarthritis (OA). This was a...
8.
Ahdieh H, Ma T, Babul N, Lee D
J Clin Pharmacol
. 2004 Jun;
44(7):767-76.
PMID: 15199081
Patients with moderate or severe pain following knee arthroplasty and washout from standard patient-controlled analgesia (PCA) were randomized to receive 20 mg of an extended-release (ER) oxymorphone formulation (n =...
9.
Thipphawong J, Babul N, Morishige R, Findlay H, Reber K, Millward G, et al.
Anesthesiology
. 2003 Sep;
99(3):693-700; discussion 6A.
PMID: 12960555
Background: The AERx Pain Management System (Aradigm Corporation, Hayward, CA) is a novel pulmonary delivery system for the systemic administration of morphine. The authors compared the relative analgesic efficacy and...
10.
Caldwell J, Rapoport R, Davis J, Offenberg H, Marker H, Roth S, et al.
J Pain Symptom Manage
. 2002 May;
23(4):278-91.
PMID: 11997197
A randomized, 4-week, double-blind trial followed by an open-label extension trial assessed the efficacy and safety of a once-daily, extended-release morphine formulation (Avinza (previously referred to as Morphelan)) in 295...